Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Phylogenetic estimates of SARS-CoV-2 introductions into Washington State

Diana M. Tordoff, Alexander L. Greninger, Pavitra Roychoudhury, Lasata Shrestha, Hong Xie, Keith R. Jerome, Nathan Breit, Meei-Li Huang, Mike Famulare, Joshua T. Herbeck
doi: https://doi.org/10.1101/2021.04.05.21254924
Diana M. Tordoff
1University of Washington, Department of Epidemiology, Seattle, WA
3Institute for Disease Modeling, Seattle, WA
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dtordoff@uw.edu
Alexander L. Greninger
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pavitra Roychoudhury
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lasata Shrestha
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Xie
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith R. Jerome
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
5Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Breit
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meei-Li Huang
2University of Washington, Department of Laboratory Medicine & Pathology, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Famulare
3Institute for Disease Modeling, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua T. Herbeck
3Institute for Disease Modeling, Seattle, WA
4International Clinical Research Center, University of Washington, Department of Global Health, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The first confirmed case of SARS-CoV-2 in North America was identified in Washington state on January 21, 2020. We aimed to quantify the number and temporal trends of out-of-state introductions of SARS-CoV-2 into Washington.

Methods We conducted a phylogenetic analysis of 11,422 publicly available whole genome SARS-CoV-2 sequences from GISAID sampled between December 2019 and September 2020. We used maximum parsimony ancestral state reconstruction methods on time-calibrated phylogenies to enumerate introductions/exports, their likely geographic source (e.g. US, non-US, and between eastern and western Washington), and estimated date of introduction. To incorporate phylogenetic uncertainty into our estimates, we conducted 5,000 replicate analyses by generating 25 random time-stratified samples of non-Washington reference sequences, 20 random polytomy resolutions, and 10 random resolutions of the reconstructed ancestral state.

Results We estimated a minimum 287 separate introductions (median, range 244-320) into Washington and 204 exported lineages (range 188-227) of SARS-CoV-2 out of Washington. Introductions began in mid-January and peaked on March 29, 2020. Lineages with the Spike D614G variant accounted for the majority (88%) of introductions. Overall, 61% (range 55-65%) of introductions into Washington likely originated from a source elsewhere within the US, while the remaining 39% (range 35-45%) likely originated from outside of the US. Intra-state transmission accounted for 65% and 28% of introductions into eastern and western Washington, respectively.

Conclusions There is phylogenetic evidence that the SARS-CoV-2 epidemic in Washington is continually seeded by a large number of introductions, and that there was significant inter- and intra-state transmission. Due to incomplete sampling our data underestimate the true number of introductions.

Competing Interest Statement

ALG reports personal fees from Abbott Molecular, grants from Merck, grants from Gilead, outside the submitted work. DMT, PR, LS, HX, KRJ, NB, MLH, MF and JTH declare no competing interests.

Funding Statement

DMT receives support from the NIH National Institute of Allergy And Infectious Diseases (F31AI152542). JTH and DMT also receive support from the NIH National Institute of Allergy and Infectious Disease (R01AI127232). Funders had no role in study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit the paper for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The use of residual clinical specimens for sequencing was approved by the institutional review board at the University of Washington with a waiver of informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are openly available via GISAID at https://www.gisaid.org/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Phylogenetic estimates of SARS-CoV-2 introductions into Washington State
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Phylogenetic estimates of SARS-CoV-2 introductions into Washington State
Diana M. Tordoff, Alexander L. Greninger, Pavitra Roychoudhury, Lasata Shrestha, Hong Xie, Keith R. Jerome, Nathan Breit, Meei-Li Huang, Mike Famulare, Joshua T. Herbeck
medRxiv 2021.04.05.21254924; doi: https://doi.org/10.1101/2021.04.05.21254924
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Phylogenetic estimates of SARS-CoV-2 introductions into Washington State
Diana M. Tordoff, Alexander L. Greninger, Pavitra Roychoudhury, Lasata Shrestha, Hong Xie, Keith R. Jerome, Nathan Breit, Meei-Li Huang, Mike Famulare, Joshua T. Herbeck
medRxiv 2021.04.05.21254924; doi: https://doi.org/10.1101/2021.04.05.21254924

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1974)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11138)
  • Forensic Medicine (8)
  • Gastroenterology (633)
  • Genetic and Genomic Medicine (3206)
  • Geriatric Medicine (310)
  • Health Economics (570)
  • Health Informatics (2056)
  • Health Policy (865)
  • Health Systems and Quality Improvement (793)
  • Hematology (311)
  • HIV/AIDS (688)
  • Infectious Diseases (except HIV/AIDS) (12753)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (320)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3008)
  • Nursing (168)
  • Nutrition (467)
  • Obstetrics and Gynecology (592)
  • Occupational and Environmental Health (615)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (917)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2812)
  • Public and Global Health (5625)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)